Figure 5.
T- and NK-cell activation as determined by CD69 up-regulation. Surface CD69 expression on peripheral blood T-cell subsets and NK cells following study therapy in one representative case (KS203). The figures represent CD69 (bold line) overlaid with IgG2b isotype control (thin line) following the first of 2 intravenous treatments.